What is the best antibiotic for burns in a patient allergic to Keflex (Cephalexin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antibiotics for Burns in Patients with Cephalexin Allergy

For patients with burns who are allergic to cephalexin (Keflex), clindamycin is the recommended first-line antibiotic therapy due to its excellent coverage against common burn pathogens and safety in patients with cephalosporin allergies. 1

Antibiotic Selection Algorithm

First-line options:

  • Clindamycin: 300-450 mg orally four times daily for adults or 20 mg/kg/day in 3 divided doses for children 1
    • Provides excellent coverage against Staphylococcus aureus (including MSSA) and Streptococcus species
    • Safe in patients with cephalosporin allergies
    • Note: Monitor for potential cross-resistance in erythromycin-resistant strains 1

Alternative options based on severity:

  • For mild to moderate burns:

    • Trimethoprim-sulfamethoxazole: 1-2 double-strength tablets twice daily for adults 1
      • Bactericidal activity against many common skin pathogens
      • No cross-reactivity with cephalosporins 1
  • For moderate to severe burns:

    • Linezolid: 600 mg orally twice daily for adults 1
      • No cross-reactivity with beta-lactams
      • Effective against MRSA and other resistant gram-positive organisms
      • More expensive option 1
  • For severe burns requiring IV therapy:

    • Vancomycin: 30 mg/kg/day in 2 divided doses IV for adults 1
      • Parenteral drug of choice for serious infections in penicillin/cephalosporin allergic patients
      • Effective against MRSA 1

Important Considerations for Cephalexin Allergy

  • The nature of the cephalexin allergy is important to determine:

    • Immediate-type (IgE-mediated) reactions: Avoid other cephalosporins with similar side chains 1
    • Non-severe delayed-type reactions: May consider cephalosporins with dissimilar side chains 1
  • Cross-reactivity between cephalosporins is primarily based on R1 side chains, not the beta-lactam ring itself 1

    • Cephalexin shares identical R1 side chains with amoxicillin 1
    • Avoid amoxicillin/clavulanate in patients with cephalexin allergy due to potential cross-reactivity 1, 2
  • For patients with severe immediate-type reactions to cephalexin:

    • Avoid all beta-lactam antibiotics including penicillins 1
    • Clindamycin is the safest alternative 1

Special Considerations for Burns

  • Burns are prone to polymicrobial infections requiring broad-spectrum coverage 1, 3
  • Local wound cultures should guide therapy when available 3
  • Consider topical antimicrobial agents in addition to systemic therapy for limited burn areas:
    • Mupirocin ointment: Apply to lesions twice daily 1
    • Retapamulin ointment: Apply to lesions twice daily 1

Common Pitfalls to Avoid

  • Myth of 10% cross-reactivity: The widely quoted 10% cross-allergy risk between penicillins and cephalosporins is exaggerated. Actual cross-reactivity is much lower, approximately 1% 4, 2
  • Overlooking side chain similarity: Cross-reactivity is primarily determined by R1 side chain similarity, not the beta-lactam ring 1
  • Avoiding all beta-lactams unnecessarily: Third and fourth-generation cephalosporins with dissimilar side chains may be safe in patients with non-severe reactions to cephalexin 1, 2
  • Inadequate coverage: Burns often involve polymicrobial infections, so ensure the selected antibiotic provides appropriate coverage 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of septic burns with a third-generation cephalosporin (cefatriaxon).

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.